JABIL Cayey is the first manufacturer in Puerto Rico to receive plastics injection molding accreditation through the industry-managed supply chain oversight program.
The pandemic and resulting “Great Resignation” is forcing companies to re-examine their workplace cultures and employee needs. Luke Otto, executive recruiting manager at Actalent, shares insights into what today’s medtech teams are seeking in an employer.
The upcoming revision to ISO 10993-17 proposes the use of release kinetics data to support toxicological risk assessments. Manufacturers should expect that this data will be needed to help mitigate the risks identified in exhaustive extraction studies.
Nondisclosure agreements (NDAs) can help protect trade secrets and build a framework for better cooperation and understanding between parties. Following are some key areas to consider when creating an NDA.
MedExecWomen board President, Helen Routh, noted at a recent conference: “Innovation in healthcare, particularly post-COVID, requires us to work across industry sectors, alongside clinicians and payers.” Laurie Halloran, president & CEO of Halloran Consultant Group shares insights she heard from a panel of strong female leaders on how the industry can take action to improve health inequities, which will be an ongoing topic at future conferences.
How can AI become a beneficial medical device manufacturing technology? This article reviews some examples of how it excels.
New changes mean new challenges, but global harmonization could make things easier for device manufacturers in the long run.
Building fruitful development partnerships between companies, governments and researchers will enable the most promising and impactful deployments in healthcare.
A global pandemic is still upon us, but that certainly does not mean that healthcare technology innovation is standing still. To help the medical device industry look to the future and prepare, experts from regulation and academia alike are bringing attention to the acceleration and pitfalls of innovation.
Effective February 7, the agency will conduct inspections across all commodities, as well as mission-critical foreign and domestic inspections.
